ONCOLOGY: Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

from Audio Medica News - Medical News Interviews · host Susan O’Brien, MD Anderson Cancer Center, Houston

Audio Journal of Oncology, December 10th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Oblimersen Extends Survival in Chronic Lymphocytic Leukemia SUSAN O'BRIEN, MD Anderson Cancer Center, Houston REFERENCE: ASH 2007 For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology meeting in Atlanta. Sarah Maxwell reports.

Episode metadata supplied by the publisher feed · Published Dec 10, 2007

Embed this episode

Attribution link and audio player

NOW PLAYING

ONCOLOGY: Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

0:00 4:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Audio Medica News - Medical News Interviews?

This episode is 4 minutes long.

When was this Audio Medica News - Medical News Interviews episode published?

This episode was published on December 10, 2007.

Can I download this Audio Medica News - Medical News Interviews episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!